216 related articles for article (PubMed ID: 9766719)
21. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K
Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459
[TBL] [Abstract][Full Text] [Related]
22. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy.
Lerut T; Flamen P; Ectors N; Van Cutsem E; Peeters M; Hiele M; De Wever W; Coosemans W; Decker G; De Leyn P; Deneffe G; Van Raemdonck D; Mortelmans L
Ann Surg; 2000 Dec; 232(6):743-52. PubMed ID: 11088069
[TBL] [Abstract][Full Text] [Related]
23. Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer?
Torrance AD; Almond LM; Fry J; Wadley MS; Lyburn ID
Surgeon; 2015 Feb; 13(1):19-33. PubMed ID: 24206935
[TBL] [Abstract][Full Text] [Related]
24. The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team.
Berrisford RG; Wong WL; Day D; Toy E; Napier M; Mitchell K; Wajed S
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1112-6. PubMed ID: 18328726
[TBL] [Abstract][Full Text] [Related]
25. Restaging oesophageal cancer after neoadjuvant therapy with (18)F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery.
Findlay JM; Gillies RS; Franklin JM; Teoh EJ; Jones GE; di Carlo S; Gleeson FV; Maynard ND; Bradley KM; Middleton MR
Eur Radiol; 2016 Oct; 26(10):3519-33. PubMed ID: 26883329
[TBL] [Abstract][Full Text] [Related]
26. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
[TBL] [Abstract][Full Text] [Related]
27. The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
Chowdhury FU; Bradley KM; Gleeson FV
Clin Radiol; 2008 Dec; 63(12):1297-309. PubMed ID: 18996259
[TBL] [Abstract][Full Text] [Related]
28. The role of PET scan in the preoperative management of oesophageal cancer.
Liberale G; Van Laethem JL; Gay F; Goldman S; Nagy N; Coppens E; Gelin M; El Nakadi I
Eur J Surg Oncol; 2004 Nov; 30(9):942-7. PubMed ID: 15498638
[TBL] [Abstract][Full Text] [Related]
29. Impact of FDG-PET for staging of oesophageal cancer.
Imdahl A; Hentschel M; Kleimaier M; Hopt UT; Brink I
Langenbecks Arch Surg; 2004 Aug; 389(4):283-8. PubMed ID: 15197549
[TBL] [Abstract][Full Text] [Related]
30. Motion-compensated FDG PET/CT for oesophageal cancer.
Voncken FEM; Vegt E; van Sandick JW; van Dieren JM; Grootscholten C; Bartels-Rutten A; Takken SL; Sonke JJ; van de Kamer JB; Aleman BMP
Strahlenther Onkol; 2021 Sep; 197(9):791-801. PubMed ID: 33825916
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography.
Kim K; Park SJ; Kim BT; Lee KS; Shim YM
Ann Thorac Surg; 2001 Jan; 71(1):290-4. PubMed ID: 11216764
[TBL] [Abstract][Full Text] [Related]
33. Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
Gillies RS; Middleton MR; Maynard ND; Bradley KM; Gleeson FV
Eur Radiol; 2011 Feb; 21(2):274-80. PubMed ID: 20821013
[TBL] [Abstract][Full Text] [Related]
34. Role of positron emission tomography in staging esophageal cancer.
Luketich JD; Schauer PR; Meltzer CC; Landreneau RJ; Urso GK; Townsend DW; Ferson PF; Keenan RJ; Belani CP
Ann Thorac Surg; 1997 Sep; 64(3):765-9. PubMed ID: 9307471
[TBL] [Abstract][Full Text] [Related]
35. Staging investigations for oesophageal cancer: a meta-analysis.
van Vliet EP; Heijenbrok-Kal MH; Hunink MG; Kuipers EJ; Siersema PD
Br J Cancer; 2008 Feb; 98(3):547-57. PubMed ID: 18212745
[TBL] [Abstract][Full Text] [Related]
36. Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging.
Kobori O; Kirihara Y; Kosaka N; Hara T
Cancer; 1999 Nov; 86(9):1638-48. PubMed ID: 10547535
[TBL] [Abstract][Full Text] [Related]
37. Better assessment of nodal metastases by PET/CT fusion compared to side-by-side PET/CT in oesophageal cancer.
Schreurs LM; Pultrum BB; Koopmans KP; Verhoef CC; Jager PL; Van Dam GM; Groen H; Van Der Jagt EJ; Plukker JT
Anticancer Res; 2008; 28(3B):1867-73. PubMed ID: 18630473
[TBL] [Abstract][Full Text] [Related]
38. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction.
Räsänen JV; Sihvo EI; Knuuti MJ; Minn HR; Luostarinen ME; Laippala P; Viljanen T; Salo JA
Ann Surg Oncol; 2003 Oct; 10(8):954-60. PubMed ID: 14527917
[TBL] [Abstract][Full Text] [Related]
39. Lack of clinical impact of
Liu J; Larcos G; Howle J; Veness M
Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
[TBL] [Abstract][Full Text] [Related]
40. PET/CT: will it change the way that we use CT in cancer imaging?
Hicks RJ; Ware RE; Lau EW
Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
